Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk]

Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk]

Discover the superior quality of our Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk], a powerful tool for your immunological research. This antibody is meticulously designed to offer exceptional specificity and sensitivity, ensuring reliable results in your experiments. With its wide range of applications, this antibody is an essential addition to your laboratory toolkit.

Product Highlights:

• Host Species: Rabbit
• Reactivity: Human
• Applications: IHC

The Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk] is produced using a fusion protein of human CLEC1B, ensuring high affinity and specificity. It is conjugated with IgG, providing robust binding capabilities. This antibody is purified through antigen affinity purification, guaranteeing a high level of purity and minimal cross-reactivity.

Applications and Benefits

Our Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk] is ideal for immunohistochemistry (IHC) applications, allowing for the visualization of CLEC1B expression in tissue samples. This antibody is designed to help researchers study the role of CLEC1B in various biological processes, including immune responses and cell signaling. By using this antibody, you can:

• Enhance Your Research: With its high specificity and sensitivity, this antibody will help you obtain accurate and reliable results.
• Save Time and Resources: The easy-to-use format and wide range of applications make this antibody a cost-effective choice for your laboratory.

Whether you are a seasoned researcher or just starting out in the field of immunology, the Trending Clec1b Polyclonal Antibody Reactivity Human With A 30% Price Cut [D8HpNWzk] is an invaluable tool for your studies. Trust in its quality and reliability to advance your research and make significant discoveries.